Abstract:
Metabolic syndrome (MS), which includes a number of systemic clinical and biochemical
processes (insulin resistance, abdominal obesity, dyslipidemia, arterial hypertension), attracts
close attention of general practitioners. The risk factors and pathological processes leading to the
development of this syndrome remain controversial. Several hypotheses for the development of
MS have been proposed, of which the theory of insulin resistance is the leading one. To date, all
possible causes and mechanisms for the development of MS have not been finally disclosed.
Non-esterified fatty acids play an important role in the development of MS.
